Looking at how companies like Psychedelic Water could impact the future of the beverage industry and how psychedelics overall could impact the alcohol industry, in recent news a recent study published in JAMA Psychiatry has shown that psilocybin therapy, in addition to psychotherapy, reduced the number of heavy drinking days and average daily alcohol consumption in individuals with alcohol use disorder compared with an antihistamine placebo and psychotherapy.
This is the first randomised clinical trial (RCT) to show that psilocybin could help reduce excessive drinking in individuals with alcohol use disorder.
“Our findings strongly suggest that psilocybin therapy is a promising means of treating alcohol use disorder, a complex disease that has proven notoriously difficult to manage,” said study author, Dr. Michael Bogenschutz, director of New York University’s Langone Centre for Psychedelic Medicine, in a news release.
We have also recently seen a top Canadian health official who heads up the country’s efforts to combat addiction visit Colorado, Oregon and Washington State last week to learn about their experiences implementing drug policy reform like broad decriminalisation and harm reduction—meeting with the governor of Oregon and psychedelics activists, among others, on a week-long tour.
Liberal MP Carolyn Bennett, who serves as Canada’s minister of mental health and addictions, met with top state officials, activists, harm reduction professionals and law enforcement to discuss how jurisdictions on the other side of the border are addressing drug policy and working to mitigate the overdose crisis.
“We’ll be sharing evidence, talking to people with lived and living experience, and discussing how our governments can learn from one another,” the minister, who recently authorized a drug decriminalization pilot program in one of Canada’s largest provinces, said ahead of the regional tour.
Gogia is confident these trends towards decriminalisation and adoption of psychedelics by the masses will continue to move forward and he is sure Psychedelic Water will be at the forefront of product development as these developments continue.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.